An infectious diseases specialist separates fact from fiction, powering us with information about symptoms, treatments, precautions and more ...

President Joe Biden's "aggressive" prostate cancer has led to renewed interest in his health during his presidency ...

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...

Former President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has metastasized to the bone, ...

Joe Biden has faced a series of serious health issues over the decades, including two life-threatening brain aneurysms and ...

Research indicates that high-yield stock portfolios outperform over time. Does your portfolio have the right mix of ...

Joe Biden, 82, is battling an aggressive form of prostate cancer that has spread to his bones. This diagnosis adds to his ...

Weekly hospital visits for COVID-19 surged by 88 percent last week, the Centers for Disease Control (CDC) said yesterday, ...

Biden was treated for a blood clot in his lung in 1988, per The Washington Post. The clot came one month after the ...

On first glance, Dr. Vinay Prasad’s medical credentials sound impressive. But look closer and you’ll find a narcissistic ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.